Publications by authors named "Elizabeth Scalbert"

Claim this Profile
R
RhoA guanine exchange factor expression profile in arteries: evidence for a Rho kinase-dependent negative feedback in angiotensin II-dependent hypertension.
Chrystelle Cario-Toumaniantz, David Ferland-McCollough, Gilliane Chadeuf, Gilles Toumaniantz, Marianne Rodriguez, Elizabeth Scalbert

Am J Physiol Cell Physiol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure.
Christophe Guilluy, Jérémy Brégeon, Gilles Toumaniantz, Malvyne Rolli-Derkinderen, Kevin Retailleau, Elizabeth Scalbert

Nat Med· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.
Christophe Dubessy, Dorthe Cartier, Benoît Lectez, Christine Bucharles, Nicolas Chartrel, Elizabeth Scalbert

J Neurochem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of urotensin II and URP.
Jérôme Leprince, David Chatenet, Christophe Dubessy, Alain Fournier, Bruno Pfeiffer, Elizabeth Scalbert

Peptides· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioral actions of urotensin-II.
Jean-Claude do Rego, Jérôme Leprince, Elizabeth Scalbert, Hubert Vaudry, Jean Costentin

Peptides· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rho exchange factors in the cardiovascular system.
Gervaise Loirand, Elizabeth Scalbert, Antoine Bril, Pierre Pacaud

Curr Opin Pharmacol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implication of microRNAs in the cardiovascular system.
Elizabeth Scalbert, Antoine Bril

Curr Opin Pharmacol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.
David Chatenet, Christophe Dubessy, Cédric Boularan, Elizabeth Scalbert, Bruno Pfeiffer

J Med Chem· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Localization of the urotensin II receptor in the rat central nervous system.
Sylvie Jégou, Dorthe Cartier, Christophe Dubessy, Bruno J Gonzalez, David Chatenet, Elizabeth Scalbert

J Comp Neurol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioral effects of urotensin-II centrally administered in mice.
Jean-Claude Do-Rego, David Chatenet, Marie-Hélène Orta, Bertrand Naudin, Camille Le Cudennec, Elizabeth Scalbert

Psychopharmacology (Berl)· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stent implantation activates RhoA in human arteries: inhibitory effect of rapamycin.
Patrice Guérin, Vincent Sauzeau, Malvyne Rolli-Derkinderen, Oussama Al Habbash, Elizabeth Scalbert

J Vasc Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships and structural conformation of a novel urotensin II-related peptide.
David Chatenet, Christophe Dubessy, Jérôme Leprince, Cédric Boularan, Ludovic Carlier, Elizabeth Scalbert

Peptides· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of indole and tetrahydroisoquinoline hydantoin derivatives as human chymase inhibitors.
David Alagille, Bruno Pfeiffer, Elizabeth Scalbert, Gilles Ferry, Jean A Boutin

J Enzyme Inhib Med Chem· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of treatment with melatonin on cerebral circulation in old rats.
François Dupuis, Olivier Régrigny, Jeffrey Atkinson, Patrick Limiñana, Philippe Delagrange, Elizabeth Scalbert

Br J Pharmacol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melatonin inhibits nitrate tolerance in isolated coronary arteries.
Stephen T O'Rourke, Hana Hammad, Philippe Delagrange, Elizabeth Scalbert, Paul M Vanhoutte

Br J Pharmacol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of new 2-(4,5-dihydro-1H-imidazol-2-yl)-3,4-dihydro-2H-1,4-benzoxazine derivatives.
Frédérique Touzeau, Axelle Arrault, Gérald Guillaumet, Elizabeth Scalbert, Bruno Pfeiffer

J Med Chem· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction.
Patricia Labarrère, David Chatenet, Jérôme Leprince, Céline Marionneau, Gervaise Loirand, Elizabeth Scalbert

J Enzyme Inhib Med Chem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacological study of Rho-kinase inhibitors: pharmacomodulations on the lead compound Fasudil.
Cédric Logé, Xavier Siomboing, Valérie Wallez, Elizabeth Scalbert, Caroline Bennejean

J Enzyme Inhib Med Chem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACE-versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency?
Beril Tom, Ingrid M Garrelds, Elizabeth Scalbert, Alexander P A Stegmann, Frans Boomsma

Arterioscler Thromb Vasc Biol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rho-kinase inhibitors: pharmacomodulations on the lead compound Y-32885.
Cédric Logé, Valérie Wallez, Elizabeth Scalbert, Christelle Cario-Tourmaniantz, Gervaise Loirand

J Enzyme Inhib Med Chem· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-[2-(Indan-1-yl)-3-mercapto-propionyl] amino acids as highly potent inhibitors of the three vasopeptidases (NEP, ACE, ECE): In vitro and In vivo activities.
Nicolas Inguimbert, Hervé Poras, Franck Teffo, Françoise Beslot, Mohamed Selkti, Elizabeth Scalbert

Bioorg Med Chem Lett· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulation.
Véronique Bruban, Vanessa Estato, Stephan Schann, Jean-Daniel Ehrhardt, Laurent Monassier, Elizabeth Scalbert

Circulation· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis